May 8 |
While institutions invested in Soleno Therapeutics, Inc. (NASDAQ:SLNO) benefited from last week's 4.8% gain, private equity firms stood to gain the most
|
May 3 |
Soleno Therapeutics announces pricing of $138M public offering
|
May 3 |
Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common Stock
|
May 2 |
Soleno Therapeutics announces proposed common stock offering
|
May 2 |
Soleno Therapeutics Announces Proposed Public Offering of Common Stock
|
Apr 30 |
Soleno Therapeutics Announces Peer-Reviewed Publication of Data Comparing DCCR Treatment to the Natural History of Prader-Willi Syndrome
|
Apr 29 |
Soleno: Mid-2024 NDA Filing For PWS Treatment Is A Major Catalyst To Watch
|
Apr 29 |
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
|
Apr 29 |
Why Soleno Therapeutics Stock Is Skyrocketing Today
|
Apr 29 |
Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday
|